StreetInsider.com News Articles

BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission

Fri, 10 Jul 2026 07:00:00 -0400

POMPANO BEACH, Fla., July 10, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM) (“BioStem” or the “Company”), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced the filing of a Form 10 registration statement (the “Registration Statement”) with the U.S. Securities and Exchange Commission (the “SEC”) to register its shares of common stock pursuant to the Securities Exchange Act of 1934, as amended, and reaffirmed its strategic decision to pursue a listing on the Nasdaq Stock Market (“Nasdaq”).

“The filing

BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission

Fri, 10 Jul 2026 07:00:00 -0400

“The filing

BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission

Fri, 10 Jul 2026 07:00:00 -0400

“The filing

BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission

Fri, 10 Jul 2026 07:00:00 -0400

“The filing

BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission

Fri, 10 Jul 2026 07:00:00 -0400

“The filing

BioStem Technologies Publicly Files Form 10 Registration Statement with the Securities and Exchange Commission

Fri, 10 Jul 2026 07:00:00 -0400

“The filing

BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference

Wed, 10 Jun 2026 16:05:00 -0400

POMPANO BEACH, Fla., June 10, 2026 (GLOBE NEWSWIRE) -- BioStem Technologies Inc. (OTC: BSEM), a leading regenerative medicine company focused on the development, manufacturing, and commercialization of perinatal tissue allograft products, today announced that Company management will present at the Planet MicroCap Las Vegas 2026 Conference.

BioStem is scheduled to present on Wednesday, June 17, 2026, at 3:00 PM ET. Interested parties may access live and archived webcasts of presentations on the “investors” section of the Company’s website at: ir.biostemtechnologies.com.

About BioStem Technologies, Inc. (OTC:

BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference

Wed, 10 Jun 2026 16:05:00 -0400

About BioStem Technologies, Inc. (OTC:

BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference

Wed, 10 Jun 2026 16:05:00 -0400

About BioStem Technologies, Inc. (OTC:

BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference

Wed, 10 Jun 2026 16:05:00 -0400

About BioStem Technologies, Inc. (OTC:

BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference

Wed, 10 Jun 2026 16:05:00 -0400

About BioStem Technologies, Inc. (OTC:

BioStem Technologies to Present at the Planet MicroCap Las Vegas 2026 Conference

Wed, 10 Jun 2026 16:05:00 -0400

About BioStem Technologies, Inc. (OTC:

BioStem Technologies appoints three new board members

Tue, 09 Jun 2026 07:00:37 -0400

BioStem Technologies Inc. (OTC: BSEM) announced the appointment of three new board members effective June 5, 2026. Mark Glickman, Steven D. Sonenreich, and Rayna Lesser Hannaway joined the board, while Thomas Dugan and Patrick Daly resigned effective June 4, 2026.

The board changes bring the total number of directors to seven. Sonenreich was appointed to the Audit Committee and the Corporate Governance and Nominating Committee. Hannaway received appointments to the same committees. Glickman was named to the Compensation Committee and will serve as its chair.